Human peripheral blood monocytes comprise a subpopulation of 20 to 40% that is capable of responding to chemoattractants and a remaining subpopulation that cannot respond. We were able to obtain 99%-pure attractant-responsive monocytes by using a newly constructed separation chamber. The binding of the radioactive chemotactic peptide N-formylmethionyl-leucyl-[3H]phenylalanine to migrating and nonmigrating populations was then studied. The binding was saturable at room temperature in the presence of azide. Saturation occurred at 5 x 10-8 M, and 50% of the maximal binding was obtained at 10-8 M, the concentration that induced optimal chemotaxis. The nonmigrating monocytes did not bind the peptide under the same conditions, which shows that at least one reason for a nonresponsiveness to chemotaxin is apparently a lack of receptors. By Scatchard analysis we calculated an equilibrium dissociation constant ranging from 23 to 37 nM; the number of binding sites per cell ranged from 64,000 to 77,000. The binding was very rapid. Fifty percent of the optimnal binding occurred at 3.5 min, and equilibrium was reached after 20 to 30 min. Chemotactic deactivation of the monocytes reduced the number of available binding sites by 60%.
Human peripheral blood monocytes comprise a subpopulation of 20 to 40% that is capable of responding to chemoattractants and a remaining subpopulation that cannot respond. We were able to obtain 99%-pure attractant-responsive monocytes by using a newly constructed separation chamber. The binding of the radioactive chemotactic peptide N-formylmethionyl-leucyl-[3H]phenylalanine to migrating and nonmigrating populations was then studied. The binding was saturable at room temperature in the presence of azide. Saturation occurred at 5 x 10-8 M, and 50% of the maximal binding was obtained at 10-8 M, the concentration that induced optimal chemotaxis. The nonmigrating monocytes did not bind the peptide under the same conditions, which shows that at least one reason for a nonresponsiveness to chemotaxin is apparently a lack of receptors. By Scatchard analysis we calculated an equilibrium dissociation constant ranging from 23 to 37 nM; the number of binding sites per cell ranged from 64,000 to 77,000. The binding was very rapid. Fifty percent of the optimnal binding occurred at 3.5 min, and equilibrium was reached after 20 to 30 min. Chemotactic deactivation of the monocytes reduced the number of available binding sites by 60%.
Chemotaxis of phagocytes may be important in the accumulation of effector cells at sites of inflammation. Receptor-ligand interactions have been the subject of several recent studies of the basic mechanisms of chemotaxis. Receptors for chemotactic peptides have been demonstrated for human (11, 15) and rabbit (1) polymorphonuclear leukocytes and for guinea pig macrophages (14) . A receptor for the chemotactic fragment of the fifth component of complement, C5a, has been shown to be on the surface of human neutrophils (3). None of these studies addresses the possibility of a nonhomogeneity of the cell populations with respect to chemotactic responsiveness or receptor distribution. We have shown that only 20 to 40% of human blood monocytes migrate to chemoattractants and that each of these migrating cells can respond to several different attractants (6) . This has recently been confirmed by the finding that only a subpopulation responds to chemotaxins by polarization (4) . The human monocyte cell line U937 exhibits chemotaxis only when a surface receptor is expressed after induction by lymphokines (8, 12 sion containing not more than 2 x 106 monocytes per ml. The chamber was then incubated for 70 min at 37°C in moist air containing 5% CO2. By this time, attractant-responsive monocytes had migrated to the bottom surface of the filter, where they remained attached without falling into the lower compartment. The nonmigrating cells on the top of the filter were collected by resuspension with a pipette. The filter top was then wiped with a cotton swab to eliminate residual cells. The filter was removed and clamped, with the migrating-cell side exposed, to the inside of a 250-mi polypropylene tube with its neck cut off (no. 25350; Corning Glass Works, Corning, N.Y.). The migrating cells were rinsed off the filter with medium, washed once to remove traces of chemotactic factor and counted. The data on monocyte recovery and purity are presented below.
Monocyte deactivation. The monocytes were incubated for 45 min at 370C with 5 x 10-7 M fMet-LeuPhe at a cell concentration of 2 x 105 monocytes per ml of Gey balanced salt solution containing 2% bovine serum albumin. The cells were then washed twice and used for the binding assay.
Binding assay. The binding of tritiated fMet-Leu-Phe was assayed as described in the accompanying paper (10) . The cells were suspended in Gey balanced salt solution containing 2% bovine serum albumin and 1 mM sodium azide to inhibit possible ligand internalization (14) . Generally, 5 x 105 separated migrating or nonmigrating monocytes were used per assay point. The cells were incubated for 30 min at 24°C with concentrations of the radioactive peptide ranging from 10-9 to 10-7 M, with or without a 100-fold excess of the nonradioactive peptide. After incubation, the suspensions were filtered through Whatman glass fiber filters. The filters were washed with 10 ml of cold Hanks buffered salt solution containing 2% bovine serum albumin and were placed in scintillation vials with 10 ml of Ultrafluor scintillation fluid (National Diagnostics, Sommerville, N.J.). They were allowed to equilibrate for at least 3 h to obtain maximal counts. Nonspecific binding, defined as the amount of fMetLeu-[3H]Phe bound to the cells when a 100-fold excess of the nonradioactive peptide was present with the radioactive peptide, was usually less than 5% of the total radioactivity bound. Because of this low figure, all data are presented without correction for nonspecific binding.
RESULTS
Cell separation. No methods have previously been available to prepare pure monocyte suspensions suitable for chemotaxis assays. In these studies, we designed a separation chamber (Fig. 1 ) to obtain purified monocytes by chemotaxis, as described above. The approach was based on the fact that with Ficoll-Hypaqueseparated cells (comprising monocytes, lymphocytes, and approximately 0.5% neutrophils), the cells that migrated through the pores of a Nuclepore filter toward an attractant were almost exclusively monocytes. The few neutrophils that migrated fell off the polyvinylpyrrolidone-coated filters (9) . Thus, after 70 min of incubation, the attractant side of the filter was covered with monocytes, which were then rinsed off the filter relatively easily with little mechanical force. No residual cytoplasmic material was seen on the filter after it was stained. The purity of the migrating monocytes was 99 to 100%. No trypan blue-positive cells were seen, and no gross morphological changes were detected. Typically, 20 to 40% of the input monocytes were recovered from the filter bottom. This corresponds to the migration percentage for monocytes from normal human donors (6) . The total yield of migrating and nonmigrating monocytes was 75 to 90% in a series of experiments. The attractant used for the separations was a 1:500 dilution of a C5a stock solution (6) . After the separation procedure, the migrating monocytes responded to three different attractants, i.e., C5a, fMet-LeuPhe, and leukocyte-derived chemotactic factor; the percentage of cells migrating was similar for each attractant. Only 2 to 8% of the nonmigrating monocytes that were recovered from the top of the chamber responded to attractant, and this residual migration was eliminated after a second separation step. The binding data for migrating and unseparated monocytes were compared (Fig. 3) Fig. 3) . This difference is consistent with the fact that 60% of the unseparated monocytes did not respond to attractant and with the above finding that the nonmigrating monocytes bound little or no attractant.
Kinetics of binding. The migrating monocytes were incubated in 5 x 10-8 M radioactive peptide for the times indicated in Fig. 4 , which is representative of three experiments. The binding reached equilibrium after about 20 min at room temperature; 50% of the maximal binding occurred at 3.5 min. The amount bound at 60 min was consistently slightly less than that bound at 20 to 30 min. In a different experiment, a 1,000-fold excess of the unlabeled peptide was added at various times after the addition of the labeled peptide, and 5 min thereafter the amount of bound radioactivity was determined. When the unlabeled peptide was added within 10 min after the addition of the labeled peptide, 50% of the bound counts were displaced. When the interval was 20 min or more, only 20% of the counts were displaced.
Effect of specific chemotactic deactivation on binding. The effect of specific chemotactic deactivation on binding was studied with unseparat- 
DISCUSSION
Using a method that separates migrating from nonmigrating populations of human blood monocytes, we have shown that the migrating cells bound chemotactic peptide with a high affinity (KD of 23 to 37 nM). The nonmigrating population bound only small amounts of peptide, which could be attributed to the small residual number of migrating cells. Thus, the nonresponding cells appear to lack the chemotaxin receptor. Additional deficiencies in subsequent stages of the stimulus-response pathway have not been ruled out. A quantitative comparison of migrating and unseparated monocytes (Fig. 3) was consistent with the above findings and showed that the lack of peptide binding to the nonmigrated cells was not secondary to C5a exposure during the separation step.
It was shown recently that the human monocyte-like cell line U937 expresses peptide receptors only after stimulation with lymphokinecontaining supernatants (12) . Cells that did not respond to chemoattractant did not exhibit the receptor. The maximum number of binding sites for U937 was 33,000, and the KD was 15 to 30 nM. The number of sites is about half that determined by us for human blood monocytes, which may be due to the fact that the proportion of migrating cells was not considered in the calculations for the cell line.
We have previously shown that the chemotactic deactivation of human monocytes is chemotaxin specific (6, 7) . Deactivated cells are capable of responding normally to a different attractant, indicating that the migration machinery is intact and that the defect is at the level of the specific receptor, either in ligand binding or in postbinding transduction. In the present study, we found a decrease in the capacity to bind fMet-Leu-[3H]Phe after chemotactic deactivation by fMet-Leu-Phe. This decrease in the capacity to bind new peptide shows that there is an alteration at the receptor, i.e., either continued occupancy by the deactivating peptide or receptor removal.
The detection of receptor appearance and disappearance may provide a tool for the investigation of monocyte maturation and the biochemical mechanisms of chemotaxis. For example, does the absence of peptide receptors on the nonmigrating human monocytes reflect a maturational stage of the cells? The question can now be approached experimentally. In this context, the finding in the accompanying paper (10) is of great interest. The binding of the chemotactic peptide to the nonmigrating neutrophils is indistinguishable from the binding to the unseparated population that contains migrating and nonmigrating cells. Thus, the deficiency in human neutrophils appears to be subsequent to receptor-ligand binding. An investigation of these two cell types offers the possibility of learning about the transduction of information after ligand binding. Finally, our findings show that great care must be taken in correlating biochemical data from whole populations with chemotactic responses, since only a fraction of the whole population may migrate.
